RPG Life Sciences Ltd. on Monday reported a surge of 786% in web revenue to Rs 117.35 crore within the fourth quarter of the monetary yr 2024-24.
The pharmaceutical firm’s revenue for the same interval within the earlier fiscal stood at solely Rs 13.24 crore, in line with the corporate’s alternate submitting.
Income from operations for the quarter beneath overview expanded by 13% to Rs 143.09 crore, in opposition to Rs 126.99 crore that the corporate had posted within the This autumn FY24.
The Ebitda was up about 115% at Rs 30.55 crore versus Rs 14.23 crore. The Ebitda margin was at about 21% versus about 11%.
RPG Life Sciences posted exceptionally excessive income in the course of the quarter on account of a one-time achieve of Rs 109.90 crore.
The corporate attributed this to “task of surplus vacant leasehold land” with built-up buildings located at MIDC in Navi Mumbai.
Whereas it made an distinctive achieve of Rs 126.23 crore within the transaction, it additionally incurred a lack of Rs 16.33 crore on account of a hearth in the course of the interval.
Closing Dividend And Particular Dividend
When approving the monetary outcomes, the corporate’s board additionally really helpful a last dividend of Rs 20 per share. This dividend is 250% of the share’s face worth of Rs 8.
Moreover, it has additionally cleared a particular dividend of Rs 4 per fairness share. This the corporate stated was “on account of serious distinctive revenue on task of land for the monetary yr 2024-25”.
Nonetheless, the board clarified that the dividend payouts are topic to the approval of shareholders on the ensuing annual common assembly.
Shares of RPG Life Sciences closed 6.01% decrease at Rs 2,108.80 apiece on the BSE, in comparison with a 1.27% advance within the benchmark Sensex. The corporate shared the knowledge concerning the board approvals after the inventory markets had closed on Monday.
. Learn extra on Earnings by Newsstate24 Revenue.
